Industrial Automation Magazine India

Perfect Day expands global footprint and owned manufacturing capacity in India

Published on : Saturday 03-12-2022

Company secures regulatory approval in India and purchases state-of-the-art research, pilot production, and manufacturing facilities.

Mumabi, December 2022: Perfect Day Inc., has announced a deepening of its global vision and production prowess with two critical steps in India—a critical market for the company to scale its production capacity, extend its kinder, greener impact, and add top caliber talent to its team. The Food Safety and Standards Authority of India has approved the companys application for its animal-free milk proteins, opening the door for commercialization in India. In the near-term, Perfect Day will export animal-free protein produced in India to meet increasing global customer demands while it works on building a roadmap for domestic commercial opportunities.

The company also completed its acquisition of Sterling Biotech Limited (SBL), advancing the companys manufacturing capacity and owned manufacturing network. This acquisition will double the companys production capability in the near-term with the addition of four high-value assets, including two operational manufacturing facilities in Masar, Gujarat—more than returning on Perfect Days immediate investment of 1.5x the winning auction price of Rs 638 crore. These manufacturing facilities include robust precision fermentation capabilities with existing fermenters that will allow the company to expand its precision fermentation capabilities in the months ahead while continuing to service existing SBL customers in both the pharma and protein sectoras.

Were scaling our impact to all corners of the world. Expanding our commercialization and manufacturing capabilities in India is a critical step forward, said Narayan TM, Perfect Days President. Through regulatory approval and the acquisition of these state-of-the-art facilities in India, weve grown our presence in this important market, extending our ability to meet increasing global demand and deliver even more products to consumers.  

The facilities also are outfitted for other premium, pharmaceutical-grade ingredient production, including gelatin and dicalcium phosphate. This marks another chapter in Perfect Days mission as it expands its technology capabilities, ingredient innovation, and planet positive impact beyond animal-free milk proteins.

This strategic acquisition stands to vastly expand our ability to make and sell protein while leveraging our robust technology platform across new ingredient opportunities, said Ryan Pandya, CEO and co-founder of Perfect Day. Our mission is one driven by collaboration, and we look forward to working closely with Sterling Biotechs existing customers and employees as we continue to expand our investment in India and drive positive change together.